Bengt Hallberg

About

Dr. Bengt Hallberg is an Associate Professor at the University of Gothenburg, Sweden. His research primarily focuses on neuroblastoma, particularly the antitumor effects of targeted therapies and the molecular mechanisms of ALK mutations. His recent publications explore the interactions of various signaling pathways in cancer, including the PI3K-AKT pathway and the DNA damage response. Dr. Hallberg's work contributes significantly to understanding cancer biology and developing treatment strategies for high-risk neuroblastoma.